| Literature DB >> 27849515 |
Michaël Luciano Tantely1, Steven M Goodman2, Tsirinaina Rakotondranaivo1, Sébastien Boyer1.
Abstract
West Nile fever (WNF) is a zoonotic disease, occurring nearly globally. In Madagascar, West Nile virus (WNV) was first detected in 1978 from wild birds and the virus is currently distributed across the island, but no epidemic or epizootic period has been recorded. One fatal human case of WNV infection was reported in 2011, suggesting a "tip of the iceberg" phenomenon of a possible WNF epidemic/epizootic on the island. The main objective of this literature-based survey is to review patterns of WNV circulation in Madagascar from the entomological and ornithological points of view. Among the 235 mosquito species described from Madagascar, 29 species are widely associated with WNV infection; 16 of them are found naturally infected with WNV on the island and categorized into major, candidate, and potential vectors of WNV according to their vector capacity. This study upholds the hypothesis that WNV enzooticity is independent of annual movements of migratory birds passing through Madagascar. Moreover, the lack of regular migratory bird flux between Africa and Madagascar would reduce the probability of transmission and the subsequent reintroduction of the virus into locally occurring mosquito species. Given that Palearctic migratory birds are strongly implicated in the transmission of WNV, we highlight notable differences in the movements and species diversity of these birds in Madagascar as compared to eastern and northern Africa. Risk factors from this two-pronged approach are presented for the emergence of WNF outbreak. © M.L. Tantely et al., published by EDP Sciences, 2016.Entities:
Mesh:
Year: 2016 PMID: 27849515 PMCID: PMC5112766 DOI: 10.1051/parasite/2016058
Source DB: PubMed Journal: Parasite ISSN: 1252-607X Impact factor: 3.000
Biology, vector competence, and vector status of Malagasy mosquito species naturally/experimentally associated with WNV in Madagascar.
| Species | Natural infection (Ni) | Biology | Vector competence (Vc) | Vector statuts | References | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Locality | Date | Biotopeµ | FB | Density | IR | Dose | TR | Dose | Ni | Biology | Vc | ||
|
| Madagascar | Nov-12 | Lake | O | LAb | CV | [ | [ | |||||
|
| Madagascar | Dec-82 | Forest | GF | LAb | CV | [ | [ | |||||
|
| Senegal | GF | R | PV | [ | [ | |||||||
|
| Madagascar | July-83 | Forest | A | R | PV | [ | [ | |||||
|
| Madagascar | Dec-82 | Forest | A | LAb | CV | [ | [ | |||||
|
| Madagascar | Nov-82 | Forest | A | LAb | 16% | 107.2±0.3 PFU/mL | ≤16% | 107.2±0.3 PFU/mL | CV | [ | [ | [ |
|
| USA | A | Ab | 90% | 107.2±0.3 PFU/mL | 73% | 107.2±0.3 PFU/mL | CV | [ | [ | [ | ||
|
| Madagascar | Nov-12 | Lake | GF | Ab | CV | [ | [ | |||||
|
| Madagascar | May- 88 | Village | A | R | PV | [ | [ | |||||
|
| Madagascar | Dec-85 | Village | GF | LAb | PV | [ | [ | |||||
|
| Madagascar | Jun-13 | Village | GF | LAb | PV | [ | [ | |||||
|
| Uganda | A | R | PV | [ | [ | |||||||
|
| Senegal | GF | Ab | PV | [ | [ | |||||||
|
| Madagascar | Mar-88 | Village | GF | Ab | CV | [ | [ | |||||
|
| Madagascar | Feb, April, Dec-85 | Forest edge | GF | Ab | CV | [ | [ | |||||
|
| Ivory Coast | A | R | PV | [ | [ | |||||||
|
| Sengal | GF | R | PV | [ | [ | |||||||
|
| USA | GF | LAb | 17–100% | 105.2 ±0.2–107.1±0.1 PFU/mL | 2–33% | 105.2 ±0.2–107.1±0.1 PFU/mL | CV | [ | [ | [ | ||
|
| Madagascar | Feb-86 | Forest egde | GF | Ab | 8–86% | 107.1±0.1 PFU/mL | 2–52% | 107.1±0.1 PFU/mL | MV | [ | [ | [ |
|
| Madagascar | July-83 | Village | A | R | PV | [ | [ | |||||
|
| Madagascar | Dec-82 | Forest | GF | Ab | 10–90% | 100.79–102.87 SMICLD50/mL | 100% | 10−1.06 SMICLD50/mL | MV | [ | [ | [ |
|
| Madagascar | Feb-86 | Forest egde | GF | Ab | 51% | 105.8–7.2 PFU/mL | 100% | 7.0 log 10 CPD50/mL | MV | [ | [ | [ |
|
| R | 42% | 105.8–7.2 PFU/mL | 17–100% | [ | [ | |||||||
|
| CAR | A | R | PV | [ | [ | |||||||
|
| CAR | R | PV | [ | [ | ||||||||
|
| Senegal | A | R | 50% | 105.8–7.2 PFU/mL | PV | [ | [ | [ | ||||
|
| Madagascar | June-13 | Lake | GF | Ab | 43% | 105.8–7.2 PFU/mL | MV | [ | [ | [ | ||
|
| Senegal | A | R | PV | [ | [ | |||||||
|
| Senegal | unknown | R | PV | [ | [ | |||||||
In bold are mosquitoes found naturally infected with WNV in Madagascar.
This species was not specified and is morphologically close to Culex scottii [34].
Ni: natural infection, Locality: place where a mosquito was found naturally WNV-positive, USA: United States of America, CAR: Central African Republic. Date: periods of WNV detection in Madagascar in mosquitoes, Biotope: biotope where the mosquitoes found WNV-positive were collected, Lake: village around lake.
FB: feeding behavior, O: ornithophilic, Z: zoophilic (ruminants), A: anthropophilic, GF: general feeder (Z, O, A).
Ab: abundant, LAb: locally abundant, R: rare species.
Mosquitoe species captured under shrubs and undergrowth during the day [34].
Vc: Vector competence (infection rate: IR, transmission rate: TR). CPD50: cytopathic dose 50, SMICLD50: suckling mouse intracerebral 50% lethal doses, PFU: plaque-forming unit.
MV: major WNV vector, CV: candidate vector, PV: potential vector.